340 related articles for article (PubMed ID: 23001293)
21. Transcriptional activities of mutant p53: when mutations are more than a loss.
Kim E; Deppert W
J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
[TBL] [Abstract][Full Text] [Related]
22. Posttranslational phosphorylation of mutant p53 protein in tumor development.
Matsumoto M; Furihata M; Ohtsuki Y
Med Mol Morphol; 2006 Jun; 39(2):79-87. PubMed ID: 16821145
[TBL] [Abstract][Full Text] [Related]
23. Hsp90 is essential for restoring cellular functions of temperature-sensitive p53 mutant protein but not for stabilization and activation of wild-type p53: implications for cancer therapy.
Müller P; Ceskova P; Vojtesek B
J Biol Chem; 2005 Feb; 280(8):6682-91. PubMed ID: 15613472
[TBL] [Abstract][Full Text] [Related]
24. Tumour suppression by p53: the importance of apoptosis and cellular senescence.
Zuckerman V; Wolyniec K; Sionov RV; Haupt S; Haupt Y
J Pathol; 2009 Sep; 219(1):3-15. PubMed ID: 19562738
[TBL] [Abstract][Full Text] [Related]
25. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.
Ferraiuolo M; Verduci L; Blandino G; Strano S
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28467351
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in p53 research: an interdisciplinary perspective.
Olivier M; Petitjean A; Marcel V; Pétré A; Mounawar M; Plymoth A; de Fromentel CC; Hainaut P
Cancer Gene Ther; 2009 Jan; 16(1):1-12. PubMed ID: 18802452
[TBL] [Abstract][Full Text] [Related]
27. Wild-type p53 in cancer cells: when a guardian turns into a blackguard.
Kim E; Giese A; Deppert W
Biochem Pharmacol; 2009 Jan; 77(1):11-20. PubMed ID: 18812169
[TBL] [Abstract][Full Text] [Related]
28. The role of mutant p53 in human cancer.
Goh AM; Coffill CR; Lane DP
J Pathol; 2011 Jan; 223(2):116-26. PubMed ID: 21125670
[TBL] [Abstract][Full Text] [Related]
29. Drugging in the absence of p53.
Aning OA; Cheok CF
J Mol Cell Biol; 2019 Mar; 11(3):255-264. PubMed ID: 30865230
[TBL] [Abstract][Full Text] [Related]
30. Functions of p53 in metabolism and invasion.
Vousden KH
Biochem Soc Trans; 2009 Jun; 37(Pt 3):511-7. PubMed ID: 19442244
[TBL] [Abstract][Full Text] [Related]
31. Identification of GRO1 as a critical determinant for mutant p53 gain of function.
Yan W; Chen X
J Biol Chem; 2009 May; 284(18):12178-87. PubMed ID: 19258312
[TBL] [Abstract][Full Text] [Related]
32. Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Donehower LA; Soussi T; Korkut A; Liu Y; Schultz A; Cardenas M; Li X; Babur O; Hsu TK; Lichtarge O; Weinstein JN; Akbani R; Wheeler DA
Cell Rep; 2019 Jul; 28(5):1370-1384.e5. PubMed ID: 31365877
[TBL] [Abstract][Full Text] [Related]
33. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
Jafarnejad SM; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
[TBL] [Abstract][Full Text] [Related]
34. [The p53 gene and protein in 2005: new results, promising opportunities].
Szoke D; Sipos F; Spisák S; Molnár B; Tulassay Z
Orv Hetil; 2005 Jul; 146(30):1587-94. PubMed ID: 16136736
[TBL] [Abstract][Full Text] [Related]
35. Prion-like aggregation of mutant p53 in cancer.
Silva JL; De Moura Gallo CV; Costa DC; Rangel LP
Trends Biochem Sci; 2014 Jun; 39(6):260-7. PubMed ID: 24775734
[TBL] [Abstract][Full Text] [Related]
36. Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action.
Wawrzynow B; Zylicz A; Zylicz M
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):161-174. PubMed ID: 29355591
[TBL] [Abstract][Full Text] [Related]
37. p53: the attractive tumor suppressor in the cancer research field.
Ozaki T; Nakagawara A
J Biomed Biotechnol; 2011; 2011():603925. PubMed ID: 21188172
[TBL] [Abstract][Full Text] [Related]
38. Negative control elements of the cell cycle in human tumors.
Adams PD; Kaelin WG
Curr Opin Cell Biol; 1998 Dec; 10(6):791-7. PubMed ID: 9914179
[TBL] [Abstract][Full Text] [Related]
39. Mutant p53: an oncogenic transcription factor.
Strano S; Dell'Orso S; Di Agostino S; Fontemaggi G; Sacchi A; Blandino G
Oncogene; 2007 Apr; 26(15):2212-9. PubMed ID: 17401430
[TBL] [Abstract][Full Text] [Related]
40. ATF3 regulates the stability of p53: a link to cancer.
Yan C; Boyd DD
Cell Cycle; 2006 May; 5(9):926-9. PubMed ID: 16628010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
